These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 9759746
1. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Sidhu H, Hoppe B, Hesse A, Tenbrock K, Brömme S, Rietschel E, Peck AB. Lancet; 1998 Sep 26; 352(9133):1026-9. PubMed ID: 9759746 [Abstract] [Full Text] [Related]
2. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis. Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A. Am J Kidney Dis; 2005 Sep 26; 46(3):440-5. PubMed ID: 16129205 [Abstract] [Full Text] [Related]
3. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB. J Am Soc Nephrol; 1999 Nov 26; 10 Suppl 14():S334-40. PubMed ID: 10541258 [Abstract] [Full Text] [Related]
4. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. Troxel SA, Sidhu H, Kaul P, Low RK. J Endourol; 2003 Apr 26; 17(3):173-6. PubMed ID: 12803990 [Abstract] [Full Text] [Related]
5. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study. Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A. BJU Int; 2020 Jan 26; 125(1):133-143. PubMed ID: 31145528 [Abstract] [Full Text] [Related]
6. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis. Vaidyanathan S, von Unruh GE, Watson ID, Laube N, Willets S, Soni BL. ScientificWorldJournal; 2006 Apr 06; 6():2403-10. PubMed ID: 17619709 [Abstract] [Full Text] [Related]
7. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. Mittal RD, Kumar R, Bid HK, Mittal B. J Endourol; 2005 Apr 06; 19(1):102-6. PubMed ID: 15735393 [Abstract] [Full Text] [Related]
8. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation. Kumar R, Ghoshal UC, Singh G, Mittal RD. J Gastroenterol Hepatol; 2004 Dec 06; 19(12):1403-9. PubMed ID: 15610315 [Abstract] [Full Text] [Related]
9. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Neuhaus TJ, Belzer T, Blau N, Hoppe B, Sidhu H, Leumann E. Arch Dis Child; 2000 Apr 06; 82(4):322-6. PubMed ID: 10735843 [Abstract] [Full Text] [Related]
10. A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Hoppe B, Niaudet P, Salomon R, Harambat J, Hulton SA, Van't Hoff W, Moochhala SH, Deschênes G, Lindner E, Sjögren A, Cochat P. Pediatr Nephrol; 2017 May 06; 32(5):781-790. PubMed ID: 27924398 [Abstract] [Full Text] [Related]
11. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Hoppe B, Dittlich K, Fehrenbach H, Plum G, Beck BB. Am J Kidney Dis; 2011 Sep 06; 58(3):453-5. PubMed ID: 21705122 [Abstract] [Full Text] [Related]
12. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis. Sikora P, Niedźwiadek J, Mazur E, Paluch-Oleś J, Zajaczkowska M, Kozioł-Montewka M. Arch Med Res; 2009 Jul 06; 40(5):369-73. PubMed ID: 19766900 [Abstract] [Full Text] [Related]
13. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis. Batislam E, Yilmaz E, Yuvanc E, Kisa O, Kisa U. Urol Res; 2012 Oct 06; 40(5):455-60. PubMed ID: 22215293 [Abstract] [Full Text] [Related]
14. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H. Kidney Int; 2006 Oct 06; 70(7):1305-11. PubMed ID: 16850020 [Abstract] [Full Text] [Related]
15. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Kwak C, Kim HK, Kim EC, Choi MS, Kim HH. Eur Urol; 2003 Oct 06; 44(4):475-81. PubMed ID: 14499684 [Abstract] [Full Text] [Related]
16. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB. J Urol; 2001 Oct 06; 166(4):1487-91. PubMed ID: 11547118 [Abstract] [Full Text] [Related]
17. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A. Kidney Int; 2013 Jun 06; 83(6):1144-9. PubMed ID: 23536130 [Abstract] [Full Text] [Related]
18. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition. Verhulst A, Dehmel B, Lindner E, Akerman ME, D'Haese PC. Urolithiasis; 2022 Apr 06; 50(2):119-130. PubMed ID: 35122487 [Abstract] [Full Text] [Related]
19. Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells. Arvans D, Chang C, Alshaikh A, Tesar C, Babnigg G, Wolfgeher D, Kron S, Antonopoulos D, Bashir M, Cham C, Musch M, Chang E, Joachimiak A, Hassan H. Am J Physiol Cell Physiol; 2023 Jul 01; 325(1):C344-C361. PubMed ID: 37125773 [Abstract] [Full Text] [Related]
20. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD. Eur Urol; 2002 Mar 01; 41(3):318-22. PubMed ID: 12180235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]